| Patents for C07K 1 - General processes for the preparation of peptides (51,718) |
|---|
| 09/17/1992 | CA2103901A1 Insecticidally effective peptides isolatable from diguetia spider venom |
| 09/17/1992 | CA2081481A1 Biosynthetic cerebrospinal fluid control and method of use |
| 09/16/1992 | WO1992016230A1 Lipid a analog/immunogenic carrier conjugates, the use thereof as vaccines and polyvalent hyperimmune gammaglobulins |
| 09/16/1992 | WO1992016221A1 Pegylation of polypeptides |
| 09/16/1992 | EP0504064A1 Novel thrombin inhibitors |
| 09/16/1992 | EP0504031A1 Process and apparatus to obtain tridimensional conformations of a macromolecule in thermodynamical equilibrium from its chemical structure |
| 09/16/1992 | EP0503991A1 Process for preparing a highly purified standardized concentrate of human von Willebrand factor on industrial scale, appropriate for therapeutic use |
| 09/16/1992 | EP0503950A2 Method of purifying recombinant hepatitis B virus surface proteins from recombinant cells |
| 09/16/1992 | EP0503683A1 A process for the manufacture of peptides by solid phase synthesis |
| 09/16/1992 | EP0503293A1 Specific chicken egg antibody and method for its production |
| 09/16/1992 | EP0503203A1 Novel thrombin inhibitors |
| 09/16/1992 | EP0502928A1 METHODS OF DETECTING COLLAGEN DEGRADATION -i(IN VIVO). |
| 09/16/1992 | EP0502892A1 THE HUMAN C3b/C4b RECEPTOR (CR1) |
| 09/16/1992 | EP0470128A4 Active carbonates of polyalkylene oxides for modification of polypeptides |
| 09/16/1992 | CA2105965A1 Lipid a analog/immunogenic carrier conjugates, the use thereof as vaccines and polyvalent hyperimmune gammaglobulins |
| 09/16/1992 | CA2062460A1 A method of stabilizing recombinant hepatitis b virus surface proteins from recombinant host cells |
| 09/15/1992 | US5147855 Modified vasoactive intestinal peptide |
| 09/15/1992 | US5147782 Protease inhibitor, buffer, chelate compound |
| 09/15/1992 | US5147638 Tumor necrosis factor, antibodies, cytokines |
| 09/15/1992 | US5147608 Apparatus and process for performing repetitive chemical processing |
| 09/15/1992 | CA1307623C Method for synthesizing a peptide containing a non-peptide bond |
| 09/09/1992 | EP0502812A1 Recombinant antibodies specific for a growth factor receptor |
| 09/09/1992 | EP0502595A2 Amide chelates, their metal complexes and their use in diagnosis and therapy |
| 09/09/1992 | EP0502160A1 Aids therapy and vaccine |
| 09/09/1992 | EP0502131A1 Production of multimeric glycoproteins through chemical coupling |
| 09/09/1992 | EP0502113A1 Chemically modified hemoglobin as an effective, stable, non-immunogenic red blood cell substitute |
| 09/09/1992 | EP0502050A1 A protein purification method. |
| 09/09/1992 | EP0457898A4 Proteinase inhibitory agents and methods for their use |
| 09/09/1992 | EP0348508B1 Process for separating and purifying lactoferrin from milk using sulfate compound |
| 09/09/1992 | EP0316322B1 Tetrapeptide inhibiting the proliferation cycle of haematopoietic strain cells, methods of production and applications thereof |
| 09/09/1992 | CN1064217A Pneumococcal polysaccharide conjugate vaccine |
| 09/08/1992 | US5145872 Enzyme inhibitors, analgesics |
| 09/08/1992 | CA2062454A1 Amide-chelates, their metal complexes as well as their use in diagnosis and treatment |
| 09/08/1992 | CA1307374C Peptides containing an aliphatic-aromatic ketone side chain |
| 09/08/1992 | CA1307373C Process for the isolation and preparation of a pasteurized alpha_-antiplasmin product |
| 09/08/1992 | CA1307289C2 Peptidylaminodiols |
| 09/08/1992 | CA1307234C Pulsed field gradient gel electrophoretic apparatus |
| 09/08/1992 | CA1307220C Reagent stabilization in enzyme-donor and acceptor assay |
| 09/08/1992 | CA1307218C Onco-fetal specific monoclonal antibodies methods of preparation and use |
| 09/03/1992 | WO1992014869A1 Crystallizing biological macromolecules in microgravity |
| 09/03/1992 | WO1992014843A1 Aptamer specific for biomolecules and method of making |
| 09/03/1992 | WO1992014754A1 Process for the phosphorylation of insulin and product produced thereby |
| 09/03/1992 | WO1992014749A1 Thyroid-derived chondrocyte-stimulating factor |
| 09/03/1992 | WO1992014747A1 Improvements in or relating to electrophoresis |
| 09/03/1992 | DE4106570A1 Neue inhibitoren der endothelzell-proliferation New inhibitors of endothelial cell proliferation- |
| 09/03/1992 | CA2104698A1 Aptamers specific for biomolecules and methods of making |
| 09/02/1992 | WO1992015695A1 Process for the c-terminal modification of peptides having a c_terminal penultimate proline residue |
| 09/02/1992 | WO1992015679A1 Improved epitode displaying phage |
| 09/02/1992 | EP0501779A1 Antibodies reactive with human cytosolic phospholipase A2 |
| 09/02/1992 | EP0501445A1 Pharmaceutical composition comprising interleukin-2 |
| 09/02/1992 | EP0501280A2 Renin-inhibiting peptide analogues |
| 09/02/1992 | EP0501215A2 Fusion proteins with monoclonal antibody, Linker and beta Glucuronidase for prodrug activation; preparation and use thereof |
| 09/02/1992 | EP0500989A1 N-(alpha-substituted-pyridinyl) carbonyl dipeptide antihypertensive agents |
| 09/02/1992 | EP0500785A1 A human t cell reactive feline protein (trfp) isolated from house dust and uses therefor |
| 09/02/1992 | EP0500784A1 Flow-rate controlled surface charge coating for capillary electrophoresis |
| 09/02/1992 | EP0500685A1 Method to identify analyte-binding ligands |
| 09/02/1992 | EP0246279B1 Method for isolation of recombinant polypeptides in biologically active forms |
| 09/02/1992 | CN1064080A Peptide compounds, process for preparation thereof and pharmaceutical composition comprising same |
| 09/02/1992 | CA2105303A1 Display phage |
| 09/02/1992 | CA2101074A1 Process for the c-terminal modification of peptides having a c-terminal penultimate proline residue |
| 09/02/1992 | CA2062065A1 Peptide analogues |
| 09/02/1992 | CA2061738A1 Antibodies reactive with human cytosolic phospholipase a2 |
| 09/01/1992 | US5144616 Laser diode and multibeam optical head using the laser diode |
| 09/01/1992 | US5144006 Oxidative folding of peptide and protein substrates using hydrocarbon sulfoxides |
| 09/01/1992 | US5143854 Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof |
| 09/01/1992 | US5143851 Method for separating diphenylurea (dpu) and phenylthiohydantoin-tryptophan (pth-trp) allowing unambiguous identification of trp in automatic sequence analysis |
| 09/01/1992 | US5143844 Construction of an igg binding protein to facilitate downstream processing using protein engineering |
| 09/01/1992 | US5143753 Bonded polymer coating of internal surface of a silica-containing capillary |
| 09/01/1992 | CA1306961C Production and characterization of hybridoma antibodies directedspecifically against common determinant(s) present among closely related, but distinct proteins |
| 08/28/1992 | WO1992015608A1 N-(α-SUBSTITUTED-PYRIDINYL)CARBONYL DIPEPTIDE ANTIHYPERTENSIVE AGENTS |
| 08/28/1992 | CA2081471A1 N-(ó-substituted-pyridinyl) carbonyl dipeptide antihypertensive agents |
| 08/28/1992 | CA2061918A1 Pharmaceutical compositions comprising a lymphokine |
| 08/26/1992 | EP0500108A2 Improved activation of recombinant proteins |
| 08/26/1992 | EP0472658A4 Fusion proteins having an in vivo post-translational modification site and methods of manufacture and purification |
| 08/25/1992 | US5141924 Synthetic vasoactive intestinal peptide analogs |
| 08/25/1992 | US5141856 Expression of purified ciliary neurotrophic factor |
| 08/25/1992 | US5141851 Isolated farnesyl protein transferase enzyme |
| 08/25/1992 | US5141648 Methods for isolating compounds using cleavable linker bound matrices |
| 08/23/1992 | WO1992014702A1 Compounds and methods for sequencing amino acids |
| 08/20/1992 | WO1992014211A1 Method for modelling the electron density of a crystal |
| 08/20/1992 | WO1992013965A1 Method of immobilizing and crosslinking proteins and other molecules and uses thereof |
| 08/20/1992 | WO1992013889A1 Nematode vaccine |
| 08/20/1992 | WO1992013880A1 Novel peptide |
| 08/20/1992 | WO1992013878A2 Conformationally restricted mimetics of beta turns and beta bulges and peptides containing the same |
| 08/20/1992 | WO1992013875A1 Improved blood substitute |
| 08/20/1992 | WO1992013447A1 Template polymerization using metal chelates and fluid imprint matrices |
| 08/20/1992 | WO1992006113A3 Derivatives of gp160 and vaccines based on gp160 or a derivative thereof, containing an adjuvant |
| 08/20/1992 | CA2103577A1 Conformationally restricted mimetics of beta turns and beta bulges and peptides containing the same |
| 08/20/1992 | CA2079870A1 Vaccine |
| 08/19/1992 | EP0499541A1 Process for the purification of a highly glycosylated protein |
| 08/19/1992 | EP0499176A2 Monoclonal antibodies against human pancreatic islet cells |
| 08/19/1992 | EP0499162A2 GM-CSF inhibiting oligopeptides |
| 08/19/1992 | EP0499127A1 Conduit plate for fluid delivery system |
| 08/19/1992 | EP0499080A2 Aminoacid derivatibes |
| 08/19/1992 | EP0498801A1 Solid surface for peptide synthesis |
| 08/19/1992 | EP0340245B1 Substituted alkylamides of teicoplanin compounds |
| 08/19/1992 | CN1017867B Method of preparing covaluently-modified neutral bacterial poly-saccharides and thereof covalent conjugates of such polysaccharides and immunogenic protein |
| 08/18/1992 | US5140103 Quanitative analysis of telopeptides crosslinked by hydroxylysyl pyridinoline(HP) or lysyl pyridinoline(LP) derived from bone collagen reabsorption |
| 08/18/1992 | US5140009 Stable against proteolytic enzymes; anticarcinogenic agents; urogenital disorders |
| 08/18/1992 | US5139953 For specific adsorption of minor constituents in a liquid containing immobilized enzymes and carriers |